Imagion Biosystems Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 1.048x

Imagion Biosystems Ltd cash flow conversion efficiency. Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has a cash flow conversion efficiency ratio of 1.048x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.27 Million ≈ $-1.60 Million USD) by net assets (AU$-2.16 Million ≈ $-1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Imagion Biosystems Ltd (2014–2025)

Cash flow conversion efficiency of Imagion Biosystems Ltd from 2014 to 2025. This chart illustrates how Imagion Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View IBX stock price and chart for real-time trading data and today's change.

Imagion Biosystems Ltd Cash Flow Conversion Ratio Explained

Imagion Biosystems Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Imagion Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imagion Biosystems Ltd ranked by their cash flow conversion efficiency. Also see Imagion Biosystems Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Interactive Strength Inc. Common Stock NASDAQ:TRNR	-0.352x
Osteopore Ltd AU:OSX	0.739x
Regional REIT Ltd LSE:RGL	0.026x
EZGO Technologies Ltd NASDAQ:EZGO	-0.047x
Redcentric LSE:RCN	0.133x
Panther Metals Ltd AU:PNT	-0.034x
Eagle Eye Solutions Group plc LSE:EYE	0.125x
Northern 2 Vct Plc LSE:NTV	-0.022x

Annual Cash Flow Conversion Efficiency for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Imagion Biosystems Ltd from 2014 to 2025. Review financial agility of Imagion Biosystems Ltd to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$-2.16 Million ≈ $-1.53 Million	AU$-4.04 Million ≈ $-2.86 Million	1.870x	+236.07%
2024-12-31	AU$-2.28 Million ≈ $-1.62 Million	AU$-1.27 Million ≈ $-899.04K	0.557x	-74.65%
2023-12-31	AU$-3.79 Million ≈ $-2.68 Million	AU$-8.32 Million ≈ $-5.88 Million	2.195x	+227.18%
2022-12-31	AU$4.68 Million ≈ $3.31 Million	AU$-8.07 Million ≈ $-5.71 Million	-1.726x	-353.14%
2021-12-31	AU$13.31 Million ≈ $9.41 Million	AU$-5.07 Million ≈ $-3.59 Million	-0.381x	-6.41%
2020-12-31	AU$12.91 Million ≈ $9.14 Million	AU$-4.62 Million ≈ $-3.27 Million	-0.358x	+74.55%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	AU$-4.18 Million ≈ $-2.96 Million	-1.406x	+33.10%
2018-12-31	AU$3.87 Million ≈ $2.74 Million	AU$-8.13 Million ≈ $-5.76 Million	-2.102x	-109.47%
2017-12-31	AU$6.95 Million ≈ $4.92 Million	AU$-6.98 Million ≈ $-4.94 Million	-1.004x	-4289.57%
2016-12-31	AU$11.69 Million ≈ $8.27 Million	AU$-267.26K ≈ $-189.10K	-0.023x	-104.80%
2015-12-31	AU$-8.86 Million ≈ $-6.27 Million	AU$-4.22 Million ≈ $-2.99 Million	0.477x	-22.14%
2014-12-31	AU$-3.97 Million ≈ $-2.81 Million	AU$-2.43 Million ≈ $-1.72 Million	0.612x	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$1.74 Million

AU$2.45 Million AUD

Market Cap Rank

#30196 Global

#1760 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$8.60